Applied Genetic Technologies Q3 Loss Widens - Quick Facts

(RTTNews) - Applied Genetic Technologies Corp. (AGTC) Wednesday reported third-quarter net loss of $3.6 million or $25.45 per share, wider than $1.6 million or $14.88 per share in the same period last year.

On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.37 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues increased to $232,000 from $116,000 last year. Analysts expected revenues of $150 thousand. The increase was primarily due to the inception of new grant-funded projects related to the Company's ACHM product candidate.